Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients
Table 1
Comparison of clinical parameters according to arterial microcalcification.
Clinical parameters
All patients () number (%)
AMiC-negative () number (%)
AMiC-positive () number (%)
Age (years)1
Mean ± SD
0.002
Sex
Men
43 (52.4)
25 (51.0)
18 (54.5)
0.754
Women
39 (47.6)
24 (49.0)
15 (45.5)
BMI (kg/m2)2
Mean ± SD
0.863
Chronic kidney disease
Diabetes
44 (53.7)
16 (32.7)
28 (84.8)
0.001
Nondiabetes
38 (46.3)
33 (67.3)
5 (15.2)
Dialysis prior to vascular access creation
67 (81.7)
39 (79.6)
28 (84.8)
0.546
HD duration before Op1
Mean ± SD (months)
0.304
Kt/V2
0.770
Residual renal function1 (mL/min)
0.114
Phosphate binder
Calcium
57 (69.5)
32 (65.3)
25 (75.8)
0.313
Noncalcium
14 (17.1)
8 (16.3)
6 (18.2)
0.827
Vitamin D
19 (23.2)
14 (28.6)
5 (15.2)
0.158
Lipid-lowering agents
27 (32.9)
14 (28.6)
13 (39.3)
0.306
AMiC: arterial microcalcification; BMI: body mass index; HD: hemodialysis; Op: operation for vascular access. These parameters were compared using Mann-Whitney test and 2these parameters were compared using Student’s -test.